Schedule 13G ownership disclosure
AMBRX BIOPHARMA INC
Security class unavailable · CUSIP: 02290A102
Event date: 2021-06-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 17,754,723
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-088827
- Form type
- SC 13G
- Filer
- Ambrx Biopharma Cayman, Inc.
- CIK
- CIK 1836056
- Filed
- Jul 02, 2021
- Reporting period
- Jun 22, 2021
- Description
- Schedule 13G beneficial ownership